Yuanyong Wang

2.0k total citations
67 papers, 1.2k citations indexed

About

Yuanyong Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yuanyong Wang has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 33 papers in Pulmonary and Respiratory Medicine and 29 papers in Cancer Research. Recurrent topics in Yuanyong Wang's work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (19 papers) and Ferroptosis and cancer prognosis (18 papers). Yuanyong Wang is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (19 papers) and Ferroptosis and cancer prognosis (18 papers). Yuanyong Wang collaborates with scholars based in China, United States and Austria. Yuanyong Wang's co-authors include Tong Lu, Xiao Sun, Wenjie Jiao, Shicheng Li, Shuncheng Miao, Wenjie Jiao, Jia Liu, Yang Wo, Yanting Dong and Di Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Gene.

In The Last Decade

Yuanyong Wang

65 papers receiving 1.2k citations

Peers

Yuanyong Wang
Guoshu Bi China
Lixin Hua China
Li Xiong China
Jana Jeschke United States
Guoshu Bi China
Yuanyong Wang
Citations per year, relative to Yuanyong Wang Yuanyong Wang (= 1×) peers Guoshu Bi

Countries citing papers authored by Yuanyong Wang

Since Specialization
Citations

This map shows the geographic impact of Yuanyong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyong Wang more than expected).

Fields of papers citing papers by Yuanyong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyong Wang. The network helps show where Yuanyong Wang may publish in the future.

Co-authorship network of co-authors of Yuanyong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyong Wang. A scholar is included among the top collaborators of Yuanyong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyong Wang. Yuanyong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jianzhang, Yuanyong Wang, Yajuan Song, et al.. (2024). CILP2 promotes hypertrophic scar through Snail acetylation by interaction with ACLY. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167202–167202. 3 indexed citations
2.
Pan, Minghong, Zhaoyang Wang, Xiaolan Wang, et al.. (2024). Melatonin Attenuates Diabetic Retinopathy by Regulating EndMT of Retinal Vascular Endothelial Cells via Inhibiting the HDAC7/FOXO1/ZEB1 Axis. Journal of Pineal Research. 76(6). e13008–e13008. 5 indexed citations
3.
Zhang, Xin, Jie Yao, Mei Xie, et al.. (2024). Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis. International Immunopharmacology. 140. 112790–112790. 4 indexed citations
4.
Zhang, Xiaotian, et al.. (2023). Effects of NBP on postoperative cognitive dysfunction in rats via Nrf 2/ARE pathway. Aging. 15(1). 276–286. 4 indexed citations
5.
Zhang, Yimeng, Peng Ding, Yuanyong Wang, et al.. (2023). HDAC7/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells. Cell Death and Disease. 14(1). 38–38. 8 indexed citations
7.
Xue, Xinying, Mei Xie, Xidong Ma, et al.. (2023). Computed tomography (CT) characteristics and pathologic basis of ciliated muconodular papillary tumors of the lung. Quantitative Imaging in Medicine and Surgery. 13(7). 4339–4349. 2 indexed citations
8.
Pang, Li, Mei Xie, Xidong Ma, et al.. (2023). Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer. BMC Cancer. 23(1). 203–203. 15 indexed citations
9.
Wang, Min, Yong Zhang, Mingchuan Liu, et al.. (2023). Exploration of a novel prognostic model based on nomogram in non-small cell lung cancer patients with distant organ metastasis: implications for immunotherapy. Translational Lung Cancer Research. 12(10). 2040–2054. 2 indexed citations
10.
Gao, H.-J., Yuanyong Wang, Guodong Shi, et al.. (2023). Association of survival with adjuvant radiotherapy for pN0 esophageal cancer. Aging. 15(8). 3158–3170. 1 indexed citations
11.
Pan, Minghong, Yuanyong Wang, Zhaoyang Wang, et al.. (2023). The mitosis-related gene OIP5 is a potential biomarker in pan-cancer. Annals of Translational Medicine. 11(2). 117–117. 3 indexed citations
12.
Wang, Yuanyong, Guofang Lu, Xinying Xue, et al.. (2022). Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment. Frontiers in Immunology. 13(34). 903758–903758. 19 indexed citations
13.
Chi, Hao, Gaoge Peng, Guo Chen, et al.. (2022). Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma. Frontiers in Oncology. 12. 975255–975255. 31 indexed citations
14.
Liang, Zhen, Jianzhang Wang, Yu Zheng, et al.. (2022). A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment. Frontiers in Genetics. 13. 917007–917007. 36 indexed citations
15.
Ma, Xidong, Mei Xie, Zhiqiang Xue, et al.. (2022). HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Computers in Biology and Medicine. 151(Pt A). 106213–106213. 14 indexed citations
16.
Yao, Jie, Mei Xie, Xidong Ma, et al.. (2022). PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance. Frontiers in Oncology. 12. 965684–965684. 16 indexed citations
17.
Wang, Zhaoyang, Changjian Shao, Yuanyong Wang, et al.. (2022). Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: A systematic review and meta-analysis. International Journal of Surgery. 104. 106767–106767. 60 indexed citations
18.
Wang, Maolong, Yuling Yang, Chuan Li, et al.. (2021). Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR‐578. Thoracic Cancer. 12(16). 2258–2264. 17 indexed citations
19.
Sun, Xiao, Yunpeng Xuan, Yandong Zhao, et al.. (2020). Relevance and prognostic ability of Twist, Slug and tumor spread through air spaces in lung adenocarcinoma. Cancer Medicine. 9(6). 1986–1998. 16 indexed citations
20.
Lu, Tong, Tong Qiu, Bin Han, et al.. (2020). Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging. Cellular Oncology. 44(2). 297–310. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026